Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mallalieu

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 29, 2016
A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [<sup>14</sup>C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [<sup>13</sup>C<sub>6</sub>]-labeled basimglurant in humansElena Guerini, Simone Schadt, Gerard Greig, et al.
Hepatology (Baltimore, Md.)|November 1, 1994
Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathyS D Taylor-Robinson, J Sargentoni, R J Mallalieu, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 9, 2016
A Framework for Health Communication Across the HIV Treatment ContinuumStella Babalola, Lynn M Van Lith, Elizabeth C Mallalieu, et al.
Pediatric Rheumatology Online Journal|August 24, 2019
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trialNavita L Mallalieu, Sunethra Wimalasundera, Joy C Hsu, et al.
AIDS and Behavior|August 2, 2019
"You Take Medications, You Live Normally": The Role of Antiretroviral Therapy in Mitigating Men's Perceived Threats of HIV in Côte d'IvoireZoé Mistrale Hendrickson, Danielle A Naugle, Natalie Tibbels, et al.
Bioorganic & Medicinal Chemistry|June 15, 2005
RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluationLee A McDermott, Mary Simcox, Brian Higgins, et al.
Annals of the Rheumatic Diseases|December 24, 2016
Low immunogenicity of tocilizumab in patients with rheumatoid arthritisGerd R Burmester, Ernest Choy, Alan Kivitz, et al.
Plos One|October 24, 2019
Bringing fear into focus: The intersections of HIV and masculine gender norms in Côte d'IvoireDanielle Amani Naugle, Natalie Jean Tibbels, Zoé Mistrale Hendrickson, et al.
Plos One|March 22, 2019
Men's perceptions of HIV care engagement at the facility- and provider-levels: Experiences in Cote d'IvoireNatalie Jean Tibbels, Zoé Mistrale Hendrickson, Danielle Amani Naugle, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|April 29, 2016
A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [<sup>14</sup>C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [<sup>13</sup>C<sub>6</sub>]-labeled basimglurant in humansElena Guerini, Simone Schadt, Gerard Greig, et al.
Hepatology (Baltimore, Md.)|November 1, 1994
Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathyS D Taylor-Robinson, J Sargentoni, R J Mallalieu, et al.
Antimicrobial Agents and Chemotherapy|February 12, 2020
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy VolunteersNavita L Mallalieu, Erica Winter, Scott Fettner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 9, 2016
A Framework for Health Communication Across the HIV Treatment ContinuumStella Babalola, Lynn M Van Lith, Elizabeth C Mallalieu, et al.
Pediatric Rheumatology Online Journal|August 24, 2019
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trialNavita L Mallalieu, Sunethra Wimalasundera, Joy C Hsu, et al.
AIDS and Behavior|August 2, 2019
"You Take Medications, You Live Normally": The Role of Antiretroviral Therapy in Mitigating Men's Perceived Threats of HIV in Côte d'IvoireZoé Mistrale Hendrickson, Danielle A Naugle, Natalie Tibbels, et al.
Bioorganic & Medicinal Chemistry|June 15, 2005
RO4383596, an orally active KDR, FGFR, and PDGFR inhibitor: synthesis and biological evaluationLee A McDermott, Mary Simcox, Brian Higgins, et al.
Annals of the Rheumatic Diseases|December 24, 2016
Low immunogenicity of tocilizumab in patients with rheumatoid arthritisGerd R Burmester, Ernest Choy, Alan Kivitz, et al.
Plos One|October 24, 2019
Bringing fear into focus: The intersections of HIV and masculine gender norms in Côte d'IvoireDanielle Amani Naugle, Natalie Jean Tibbels, Zoé Mistrale Hendrickson, et al.
Plos One|March 22, 2019
Men's perceptions of HIV care engagement at the facility- and provider-levels: Experiences in Cote d'IvoireNatalie Jean Tibbels, Zoé Mistrale Hendrickson, Danielle Amani Naugle, et al.
Pageof 5